Healthcare technology company Hyperfine announced that the FDA cleared its Optive AI software for its Swoop system, an AI-powered portable MRI system for the brain. The software upgrade marks the tenth-generation release of Optive AI.
The…
News
Ambience Healthcare develops an AI medical coding model using OpenAI’s Reinforcement Fine-Tuning technology that can record and document clinical conversations, and identify and integrate relevant ICD-10 codes for more accurate billing. The company claims…
Continue Reading
What You Should Know:
– Get a Second Opinion Inc. has officially emerged from stealth mode, unveiling its AI-powered platform designed to transform how patients understand and manage their medications.
– By analyzing a vast body of FDA…
Continue Reading
Major FDA Milestone for Pediatric Care
The U.S. Food and Drug Administration has granted pediatric approval for GE HealthCare’s Optison, marking a significant advancement in pediatric cardiac imaging. This ultrasound enhancing agent will now help…
Digital musculoskeletal care company Hinge Health, went public today on the NYSE under the symbol HNGE, raising around $437.3 million with its initial public offering, which sold 9.14 million shares. The San Francisco-based company, founded…
Continue Reading
Breakthrough Medical Imaging Technology Unveiled
GE HealthCare has revolutionized medical imaging with the introduction of Signa Sprint, an ultra-premium 1.5T MRI system that promises to transform diagnostic capabilities in cardiology and oncology. Unveiled at the…
AI-backed imaging and care coordination company Viz.ai is partnering with biotechnology company Regeneron and biopharmaceutical company Sanofi to deploy and study an AI-enabled workflow tool for COPD. Viz.ai offers a care coordination platform with more…
Continue Reading
Promise and Paradox in Cell Therapy Growth
Cell and gene therapies (CGTs) stand at the precipice of transformative growth, with Cardinal Health’s “2025 Advanced Therapies Report” projecting over 200 FDA-approved treatments and 100,000+ U.S. patients…
Josh Canavan, Head of Pharmacy at RazorMetrics
Millions of Americans are currently facing a difficult choice: either pay for expensive biologic medications or ration doses to afford basic needs. Cost-related nonadherence (CRN) is where patients…
Continue Reading
Bipartisan Legislation Targets Healthcare Innovation
Groundbreaking bipartisan legislation has been reintroduced by Senators Capito and Shaheen that could transform Medicare’s approach to digital therapeutics. The Access to Prescription Digital Therapeutics Act of 2023 aims to…
